Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2007 Jul;60(7):820-3.
doi: 10.1136/jcp.2006.039925.

Glycolysis inhibitors negatively bias blood glucose measurements: potential impact on the reported prevalence of diabetes mellitus

W S Waring  1 , L E Evans, C T Kirkpatrick
Affiliations
Comparative Study

Glycolysis inhibitors negatively bias blood glucose measurements: potential impact on the reported prevalence of diabetes mellitus

W S Waring et al. J Clin Pathol. 2007 Jul.

Abstract

Background: Blood glucose concentrations are essential in defining diabetes mellitus. Recent guidelines advocate either of two discrete methods for sample collection and processing. One of these involves addition of glycolysis inhibitors, such as sodium fluoride-potassium oxalate (NaF-KOx) to sample collection tubes, whereas the other requires immediate refrigeration and sample separation.

Aims: To examine whether the choice of the preanalytical process has any impact on subsequent glucose determinations.

Methods: 62 healthy men participated in the study during screening for diabetes. Paired venous blood samples were collected in a serum-gel tube and a tube containing NaF-KOx (both Sarstedt, Leicester, UK). Serum was promptly separated from gel tube samples and refrigerated, whereas NaF-KOx samples were not separated until immediately before analysis. Glucose concentrations were determined using an Olympus AU 2700 analyser incorporating an automated hexokinase method.

Results: Mean (95% CI) glucose concentration in serum-gel tube samples was 5.2 mmol/l (5.0 to 5.4 mmol/l), whereas the concentration in tubes containing NaF-KOx was 4.9 mmol/l (4.8 to 5.1 mmol/l). A negative bias of 0.23 mmol/l (0.16 to 0.30 mmol/l) and relative negative bias of 4.7 % (3.2% to 6.3%) were observed for samples collected in NaF-KOx tubes, consistent with the combined effects of glycolysis and dilution.

Conclusions: Bias associated with the use of NaF-KOx tubes may have a significant impact on the prevalence of fasting hyperglycaemia, according to current diagnostic criteria. The small but significant difference between preanalytical processes should be considered when screening for the presence of diabetes mellitus.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Sacks D B, Bruns D E, Goldstein D E.et al Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem 200248436–472. - PubMed
    1. World Health Organization, Department of Noncommunicable Disease Surveillance Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Geneva: WHO, 1999, http://whqlibdoc.who.int/hq/1999/WHO_NCD_NCS_99.2.pdf (accessed 17 Apr 2007)
    1. Genuth S, Alberti K G, Bennett P.et al Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Follow‐up report on the diagnosis of diabetes mellitus. Diabetes Care 2003263160–3167. - PubMed
    1. Tolstoi E. Glycolysis in bloods of normal subjects and of diabetic patients. J Biol Chem 19246069
    1. Sunderman F W, Jr, Copeland B E, MacFate R P.et al Manual of American Society of Clinical Pathologists workshop on glucose. Am J Clin Pathol 1956261355–1372. - PubMed

Publication types

-